Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphoproliferative disorders and chemokines.

V Pistoia1, A Corcione, F Dallegri

  • 1Laboratory of Oncology, G. Gaslini Institute, Genova, Italy. vitopistoia@ospedale-gaslini.ge.it

Current Drug Targets
|February 4, 2006
PubMed
Summary

Chemokine receptors like CXCR4 are upregulated in many blood cancers, potentially driving tumor growth and spread. Targeting these receptors offers a promising new therapeutic strategy for lymphoproliferative disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elexacaftor/Tezacaftor/Ivacaftor Therapy in a Child With Cystic Fibrosis and Type 1 Spinal Muscular Atrophy.

Pediatric pulmonology·2026
Same author

Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study.

Pulmonology·2024
Same author

Osteoarticular pain: therapeutic approach by paradigms.

European review for medical and pharmacological sciences·2022
Same author

Sufentanil Sublingual Tablet System: from rationale of use to clinical practice.

European review for medical and pharmacological sciences·2020
Same author

Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2020
Same author

Functional insights into nucleotide-metabolizing ectoenzymes expressed by bone marrow-resident cells in patients with multiple myeloma.

Immunology letters·2018

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Chemokines are cytokines crucial for leukocyte movement.
  • Tumor cells express chemokine receptors, influencing cancer progression, metastasis, and angiogenesis.
  • Lymphoproliferative disorders involve malignant lymphoid cells.

Purpose of the Study:

  • To review chemokine receptor expression and function in human lymphoproliferative disorders.
  • To highlight the therapeutic potential of targeting chemokine receptors in these malignancies.

Main Methods:

  • Review of existing literature on chemokine receptor expression in B and T cell malignancies.
  • Analysis of functional roles of chemokine receptors in lymphoproliferative disorders.

Main Results:

Related Experiment Videos

  • CXCR4, the receptor for CXCL12, is frequently upregulated in B and T cell malignancies.
  • Upregulated CXCR4 may contribute to the metastatic spread of neoplastic cells.
  • Other chemokine receptors are expressed but may be non-functional in certain disorders.

Conclusions:

  • Chemokine receptors are significant in lymphoproliferative disorders.
  • Targeting chemokine receptors presents a promising therapeutic avenue.
  • Antagonistic peptides targeting chemokine receptors show potential for clinical application.